Celluris
PrivateLast Round
Seed
May 30, 2025
Total Funding Raised
$10.04M
Company Overview
Celluris is a biotechnology company that develops personalized CAR-T cell immunotherapy for the treatment of hematological and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celluris Comparables
Compare Celluris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellectis | 68% | |
| Recepta Biopharma | 66% | |
| Allogene Therapeutics | 61% |
Celluris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2025 | ||||
| Grant | Nov 4, 2021 | ||||
| Accelerator | Nov 4, 2021 |
Celluris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BiotechTown | Seed, Accelerator |
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2025
$10M raised with participation from BiotechTown.
- Nov 4, 2021
$36K grant from FAPESP
Celluris Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Celluris's valuation, stock price, and market status.
Is Celluris a public or private company?
Celluris is a private company.
What is the current stock price of Celluris?
Celluris is a private company with no public stock price. Caplight tracks Celluris's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Celluris worth (valuation)?
Valuation information for Celluris is not publicly available.
Can I buy Celluris stock?
Celluris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Celluris's last funding round?
Celluris's most recent funding round was Seed on May 30, 2025.
Who are the main investors in Celluris?
Key investors in Celluris include BiotechTown, FAPESP.
Will Celluris IPO soon?
No public IPO plans have been announced for Celluris.
How can I track Celluris secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Celluris's secondary market activity and sign up for updates.